Literature DB >> 28118068

Quality of life in climacteric women.

H P G Schneider1, M Birkhäuser2.   

Abstract

Health-related quality of life (HRQoL) refers to the effects of an individual's physical state on all aspects of psychosocial functioning. For postmenopausal women, HRQoL is the only global criterion that is decisive for their daily well-being. Symptoms experienced during menopause and sociodemographic characteristics affect quality of life in postmenopausal women. In younger, symptomatic, postmenopausal women, HRQoL may be significantly diminished. However, quality of life after menopause is influenced by many additional, non-menopausal factors. In the last decades, more specific symptom lists or other questionnaires have been developed. Such scales would qualify as standardized or disease-specific by fulfilling four criteria: (1) they have been constructed on the basis of a factor analysis; (2) they consist of several subscales, each measuring a different aspect of a specific symptomatology; (3) the scales possess sound psychometric properties; and (4) they have been standardized using adequate populations of women. A variety of instruments currently dominating international practice are here reviewed. Therapeutic approaches that treat climacteric symptoms and all measures ameliorating unfavorable non-hormonal factors could improve HRQoL among postmenopausal women. This includes partnership and sexual counseling as well as psychosocial measures. Menopausal hormone therapy (MHT) may reverse this deterioration of HRQoL if it is due to postmenopausal estrogen deficiency. On the contrary, when MHT is prescribed to asymptomatic younger and older postmenopausal women, no gain in HRQoL can be obtained.

Entities:  

Keywords:  HRQoL; Menopause; estrogens; health-related quality of life; hormone therapy

Mesh:

Year:  2017        PMID: 28118068     DOI: 10.1080/13697137.2017.1279599

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  16 in total

1.  Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC-MS/MS Method.

Authors:  Meiyun Shi; Lei Yin; Yantong Sun; Can Wang; Lanlan Cai; Tinglan Zhang; Xiaotong Zhou; J Paul Fawcett; Xiaoli Gao; Jingkai Gu
Journal:  Clin Pharmacokinet       Date:  2022-09-29       Impact factor: 5.577

2.  Exploring women's perceptions and experiences of menopause among East Coast Malaysian women.

Authors:  Nurul Najmi Mohamad Ishak; Nurjasmine Aida Jamani; Siti Roshaidai Mohd Arifin; Azwanis Abdul Hadi; Karimah Hanim Abd Aziz
Journal:  Malays Fam Physician       Date:  2021-02-01

3.  Quality of life in climacteric women assisted by primary health care.

Authors:  Geraldo Edson Souza Guerra; Antônio Prates Caldeira; Fernanda Piana Santos Lima de Oliveira; Maria Fernanda Santos Figueiredo Brito; Kelma Dayana de Oliveira Silva Gerra; Carlos Eduardo Mendes D'Angelis; Luís Antônio Nogueira Dos Santos; Lucineia de Pinho; Josiane Santos Brant Rocha; Daniela Araújo Veloso Popoff
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

4.  Depressive Symptoms and Healthy Behavior Frequency in Polish Postmenopausal Women from Urban and Rural Areas.

Authors:  Mariusz Gujski; Dorota Raczkiewicz; Ewa Humeniuk; Beata Sarecka-Hujar; Artur Wdowiak; Iwona Bojar
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

5.  Vasomotor menopausal disorders as a possible result of dysfunction of the microbiota-intestine-brain axis.

Authors:  Oksana Mykolaivna Pavlovska; Kateryna Mykolaivna Pavlovska; Svitlana Mykolaivna Heryak; Stefan Volodymyrovych Khmil; Mariya Stefanivna Khmil
Journal:  J Med Life       Date:  2022-02

Review 6.  Assessment of the climacteric syndrome: a narrative review.

Authors:  Marina Sourouni; Martina Zangger; Livia Honermann; Dolores Foth; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2021-07-06       Impact factor: 2.344

7.  Factors associated with quality of life of postmenopausal women living in Iran.

Authors:  Soheila Nazarpour; Masoumeh Simbar; Fahimeh Ramezani Tehrani; Hamid Alavi Majd
Journal:  BMC Womens Health       Date:  2020-05-14       Impact factor: 2.809

8.  Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.

Authors:  Dongshan Zhu; Hsin-Fang Chung; Annette J Dobson; Nirmala Pandeya; Graham G Giles; Fiona Bruinsma; Eric J Brunner; Diana Kuh; Rebecca Hardy; Nancy E Avis; Ellen B Gold; Carol A Derby; Karen A Matthews; Janet E Cade; Darren C Greenwood; Panayotes Demakakos; Daniel E Brown; Lynnette L Sievert; Debra Anderson; Kunihiko Hayashi; Jung Su Lee; Hideki Mizunuma; Therese Tillin; Mette Kildevæld Simonsen; Hans-Olov Adami; Elisabete Weiderpass; Gita D Mishra
Journal:  Lancet Public Health       Date:  2019-10-03

9.  Effectiveness of Menosan® Salvia officinalis in the treatment of a wide spectrum of menopausal complaints. A double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Dimpfel Wilfried; Chiegoua Dipah Gwladys Nina; Bommer Silvia
Journal:  Heliyon       Date:  2021-02-10

10.  Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: a cohort study.

Authors:  Yan Li; Dong Zhao; Miao Wang; Jia-Yi Sun; Jun Liu; Yue Qi; Yong-Chen Hao; Qiu-Ju Deng; Jue Liu; Jing Liu; Min Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-02-23       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.